Plasma product manufacturer Grifols has officially opened its Bioscience Division global operations centre in Ireland.
The company is known for its pioneering achievements in the research and development of therapeutic alternatives designed to contribute to both scientific and social development.
The new facility is located at Grange Castle Business Park in Dublin and will centralise decision-making with regard to Bioscience division commercial policy, R&D and supply chain, operations Grifols relocated to Ireland in 2014. The centre is scheduled to come on stream in the first half of 2016.
Grifols generated 93.4% of its sales outside of Spain in 2014, and the company currently has direct commercial presence in 30 countries and distributes its products in 100. The Bioscience division generated sales revenue of over €2.5bn in 2014, or 75% of the group’s total net revenue.
An Taoiseach Enda Kenny TD said: “I’m delighted to welcome this investment by Grifols which will create 140 jobs in west Dublin. Ireland continues to be an attractive location for investment and I’m delighted that Dublin will host the next phase of growth by Grifols. The Irish Government will continue to work with Grifols as they expand their operations in Ireland.”
Richard Bruton TD, Minister for Jobs, Enterprise and Innovation, added: “I am delighted that Grifols, a Spanish company has chosen Ireland to invest in Ireland. One of the strongest sectors in the Irish economy is life sciences, we have a cluster of virtually all the leading world companies in this sector located in Ireland and it is a sector that we have identified as part of our Action Plan for Jobs which has significant potential for job creation. The investment by Spanish company Grifols is a testament to the quality workforce available in Ireland. This investment and the creation of 140 new jobs in Dublin is great news for the area.”